Real Time Chart
Stock Profile
Stock Fundamentals
Balance sheet

Financials

Splits

Dividends

Income

Cash Flow

Financials as reported

Income

cost Of Revenue 792,000,000

currency USD

ebit --366,000,000

filing Type 10-Q

fiscal Date 2023-03-31

fiscal Quarter 1

fiscal Year 2023

gross Profit 1,070,000,000

income Tax --384,000,000

interest Income --100,000,000

minority Interest 0

net Income 79,000,000

net Income Basic 79,000,000

operating Expense 2,228,000,000

operating Expense 2,228,000,000

operating Income --366,000,000

other Income Expense Net 0

pretax Income --305,000,000

report Date 2023-05-04

research And Development 1,131,000,000

selling General And Admin 305,000,000

symbol MRNA

total Revenue 1,862,000,000

id INCOME

key MRNA

subkey quarterly

date 2023-03-31

updated 2023-05-12
Symbol Info
Symbol Over View
Technical Analysis

MRNA stock fundamentals - income

Income

cost Of Revenue 792,000,000
currency USD
ebit --366,000,000
filing Type 10-Q
fiscal Date 2023-03-31
fiscal Quarter 1
fiscal Year 2023
gross Profit 1,070,000,000
income Tax --384,000,000
interest Income --100,000,000
minority Interest 0
net Income 79,000,000
net Income Basic 79,000,000
operating Expense 2,228,000,000

operating Expense 2,228,000,000
operating Income --366,000,000
other Income Expense Net 0
pretax Income --305,000,000
report Date 2023-05-04
research And Development 1,131,000,000
selling General And Admin 305,000,000
symbol MRNA
total Revenue 1,862,000,000
id INCOME
key MRNA
subkey quarterly
date 2023-03-31
updated 2023-05-12